BORJE S ANDERSSON to DNA Repair
This is a "connection" page, showing publications BORJE S ANDERSSON has written about DNA Repair.
Connection Strength
0.744
-
The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells. Leuk Lymphoma. 2017 11; 58(11):2705-2716.
Score: 0.327
-
HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs. Oncotarget. 2022 10 14; 13:1122-1135.
Score: 0.120
-
Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide. Anticancer Res. 2002 Jan-Feb; 22(1A):21-6.
Score: 0.114
-
Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother Pharmacol. 1996; 38(5):406-16.
Score: 0.075
-
Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: relevance of p53 and its clinical implications. Exp Hematol. 2013 Aug; 41(8):719-30.
Score: 0.062
-
Model studies of cyclophosphamide resistance in human myeloid leukemia. Cancer Treat Res. 2002; 112:211-35.
Score: 0.028
-
The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues. Cancer Res. 1994 Oct 15; 54(20):5394-400.
Score: 0.017